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Human pluripotent stem cells (hPSCs), including human embryonic
stem cells and induced pluripotent stem cells, are promising for
numerous biomedical applications, such as cell replacement therapies, tissue and whole-organ engineering, and high-throughput
pharmacology and toxicology screening. Each of these applications requires large numbers of cells of high quality; however, the
scalable expansion and differentiation of hPSCs, especially for
clinical utilization, remains a challenge. We report a simple, deﬁned,
efﬁcient, scalable, and good manufacturing practice-compatible
3D culture system for hPSC expansion and differentiation. It
employs a thermoresponsive hydrogel that combines easy manipulation and completely deﬁned conditions, free of any
human- or animal-derived factors, and entailing only recombinant protein factors. Under an optimized protocol, the 3D system enables long-term, serial expansion of multiple hPSCs lines
with a high expansion rate (∼20-fold per 5-d passage, for a 1072fold expansion over 280 d), yield (∼2.0 × 107 cells per mL of
hydrogel), and purity (∼95% Oct4+), even with single-cell inoculation, all of which offer considerable advantages relative to
current approaches. Moreover, the system enabled 3D directed
differentiation of hPSCs into multiple lineages, including dopaminergic neuron progenitors with a yield of ∼8 × 107 dopaminergic progenitors per mL of hydrogel and ∼80-fold expansion
by the end of a 15-d derivation. This versatile system may be
useful at numerous scales, from basic biological investigation to
clinical development.

H

uman pluripotent stem cells (hPSCs), including human
embryonic stem cells (hESCs) (1) and induced pluripotent
stem cells (iPSCs) (2), have the capacities for indeﬁnite in vitro
expansion and differentiation into all cell types within adults (3).
They therefore represent highly promising cell sources for numerous biomedical applications, such as cell replacement therapies (4, 5), tissue and organ engineering (6), and pharmacology
and toxicology screens (7, 8). However, these applications require
large numbers of cells of high quality (4, 6–8). For instance, ∼105
surviving dopaminergic (DA) neurons, ∼109 cardiomyocytes, or
∼109 beta cells are likely required to treat a patient with Parkinson disease (PD), myocardial infarction (MI), or type I diabetes, respectively (9). Additionally, far more cells are needed
initially because both in vitro cell culture yields and subsequent
in vivo survival of transplanted cells are typically very low. As
examples of the latter, only ∼6% of transplanted dopaminergic
neurons or ∼1% of injected cardiomyocytes reportedly survive in
rodent models several months after transplantation (10, 11).
Furthermore, there are large patient populations with degenerative diseases or organ failure (9), including over 1 million people
with PD, 1–2.5 million with type I diabetes, and ∼8 million with MI
in the United States alone (12). Large numbers of cells are also
necessary for applications such as tissue engineering, where for
example ∼1010 hepatocytes or cardiomyocytes would be required
for an artiﬁcial human liver or heart, respectively (6). Additionally,
∼1010 cells may be needed to screen a million-compound library
once (8), and advances in combinatorial chemistry, noncoding
RNAs, and investigations of complex signaling and transcriptional

networks have given rise to large libraries that can be screened
against many targets (13). Massive numbers of hPSCs may therefore
be needed to deliver on the biomedical promise of these stem cells.
In general, hPSCs require key biological signals from their
substrate, and from one another (14, 15), that promote cell
survival and rapid proliferation and that culture systems must
thus provide. Current 2D-based cell culture systems—which
suffer from inherent heterogeneity and limited scalability and
reproducibility—are emerging as a bottleneck for producing sufﬁcient numbers of high-quality cells for downstream applications
(9, 16). An attractive approach for scaling up production is to
move cell culture from 2D to 3D (9, 17), and accordingly several
3D suspension systems have been probed for hPSCs production:
cell aggregates (18–21), cells on microcarriers (22, 23), and cells
in alginate microencapsulates (24) (SI Appendix, Table S1). Although these approaches have some attractive aspects, they also
highlight signiﬁcant challenges for 3D hPSC culture (9) (SI Appendix, Table S1) including the following: (i) the use of components from human or animal tissue (e.g., Matrigel, serum, and/
or albumin), which limit reproducibility and/or scalability, pose
risks for pathogen and immunogen transfer (18–24), and are
thus problematic for good manufacturing practice (GMP) cell
production (25); (ii) substantial cell agglomeration that can in
some cases lead to differentiation and/or death (22, 23); (iii)
shear forces in agitated cultures that can compromise cell viability (18–23); (iv) limited cell expansion rates and cell yields
per volume (18–24); and (v) unclear potential for long-term
serial expansion. As an example, in a recent culture of hPSCs
within alginate hydrogel microspheres in mouse embryonic ﬁbroblast conditioned medium, 5% of the encapsulated single hPSCs
remained viable after 7 d, and an ∼10- to 20-fold expansion to
a peak density of 3 × 106 cells per mL occurred after 20 d (24).
Signiﬁcance
Human pluripotent stem cells can be cultured in vitro and differentiated into presumably all cell types of the human body, and
they therefore represent highly promising cell sources for biomedical applications such as cell therapies, tissue engineering, and
drug discovery. These applications require large numbers of highquality cells, and we report an efﬁcient, deﬁned, scalable, and
good manufacturing practice-compatible 3D system for the production of human pluripotent stem cells and their progeny. The
ease of use and ﬂexible scalability of this system makes it suitable
for numerous applications from the laboratory toward the clinic.
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To address these challenges, we report an alternative system
that expands and differentiates hPSCs within a thermoreversible hydrogel, composed of a polymeric solution that is liquid
at low temperature but solidiﬁes into an elastic hydrogel when
warmed. Cells can thus be mixed with the liquid at low temperature, suspended and grown in a solid gel at 37 °C, and
harvested and passaged by reliquifying the gel at low temperature. The resulting hydrogel offers many features that beneﬁt
hPSC biology and culture, including a 3D environment for
rapid cell growth, prevention of large cell aggregate formation,
isolation of cells from shear forces, and sufﬁcient porosity for
nutrient diffusion. Although thermoreversible materials have
been used for culturing primary cells in the laboratory (26), largescale hPSC culture presents numerous additional challenges and
constraints, including apoptosis upon cell dissociation (14) and
passaging; low survival, limited proliferation, and loss of pluripotency in suboptimal culture conditions; and a strong preference for deﬁned medium to support downstream biomedical
applications. We have accordingly investigated these challenges
and developed a chemically deﬁned system with no matrix proteins that is capable of 1072-fold expansion over 60 passages with
strong maintenance of pluripotency.
Results
Several hydrogel materials—such as alginate (24, 27), agarose
(28), and hyaluronic acid (29)—have been previously investigated for hPSC expansion or differentiation. However, to date
thermoreversible materials have not been studied in hPSC culture, despite the fact that they offer a number of promising
features for GMP-compatible, large-scale culture. In particular, they are synthetic and deﬁned, biocompatible, and enable
cell harvest or passaging by simply changing temperature at the
range from 4 °C to 37 °C, a mild process for cells. Also, they can be
readily processed (e.g., .into spheres or ﬁbers) for large bioreactors.
After initial assessment of several synthesized or commercial available thermoreversible hydrogels, we found single hPSCs could
survive and retain pluripotency marker expression in 8–10%
(wt/vol) poly(N-isopropylacrylamide)-co-poly(ethylene glycol)
(PNIPAAm-PEG) hydrogel (Mebiol Gel) (SI Appendix, Fig. S1).
Preliminary investigation showed that cell behavior in this
material was signiﬁcantly affected by multiple factors, including
the addition of an inhibitor for the RhoA GTPase signaling effector Rho kinase (ROCK) (30), extent of cell dissociation, the
culture medium (3), and initial seeding density. We therefore
conducted a multifactorial analysis to assess the promise of this
material relative to other materials or to cell-only suspensions,
identify the optimal conditions under which it supports the biology and culture of hPSC, and study the potential interactions
among numerous parameters. Thirty-six combinations of various
factors, including seeding with single cells or clusters; use of
ROCK inhibitor (RI); cell seeding density; culture medium; and
with or without PNIPAAm-PEG hydrogel scaffold, were tested
(Figs. 1 and 2). Speciﬁcally, cell dissociation promotes hPSC
apoptosis via Rho GTPase signaling (14, 31, 32); however, singlecell seeding enables more reproducible expansion during largescale hPSC production. hPSCs were thus dissociated into single
cells and either directly encapsulated into the hydrogel (termed
single-cell seeding) or—based on the poor viability observed for
single-cell dissociation in 2D (30)—ﬁrst cultured in suspension
overnight to form small clusters that were subsequently encapsulated in the gel (termed precluster seeding) (Fig. 1A). Also,
addition of RI for the ﬁrst 24 h has been shown to support
growth of single hPSCs in liquid suspension culture (19), and we
included RI for the whole culture period (4-d RI) to assess its
effects on cell expansion. Additionally, low seeding density (∼1–
2.5 × 105 cells/mL) is often used (SI Appendix, Table S1), and we
also included medium and high seeding densities (1.0 × 106 and
2.5 × 106 cells/mL, respectively). Furthermore, two media were
E5040 | www.pnas.org/cgi/doi/10.1073/pnas.1309408110

used [mTeSR and completely deﬁned Essential 8 (E8)]. Moreover, hPSC suspension in static liquid medium was also included
for comparison with the hydrogel. Finally, iPS–mesenchymal
stem cells (MSCs), an iPSC derived from human MSCs (33),
were used in this optimization.
The study revealed that (i) the hydrogel promoted high expansion rates and prevented cell agglomeration (Figs. 1B and
2A). Culturing single hPSCs in 10% (wt/vol) PNIPAAm-PEG
with E8 in the presence of RI led to the formation of dense,
uniform, and small spheroids with ∼8-, 10-, or 4.4-fold expansion
over 4 d at low, medium, or high seeding density, respectively.
However, adding RI for 1 d was insufﬁcient to support single
cells (Figs. 1B and 2A). When using mTeSR rather than E8, only
moderate (<1.6-fold) or no expansion was reached with 4-d or
1-d RI, respectively, for all of the seeding densities, indicating
a negative interaction between mTeSR and the hydrogel scaffold
(Figs. 1B and 2A). (ii) In the hydrogel and E8, preclustered
hPSCs behaved similarly to single hPSCs. However, in the
hydrogel and mTeSR with 4-d RI, preclustered hPSCs displayed
signiﬁcantly higher expansion (∼4.5-, 4.5-, 2.1-fold for low, medium, high density, respectively) than single hPSCs (Figs. 1B and
2B), indicating that mTeSR stresses single cells. (iii) For all
static-suspension cultures in liquid medium without hydrogel,
large cell aggregates were found, and only ∼2.8-, 1.6-, or 0.2-fold
expansion was achieved for low, medium, or high seeding density,
respectively (Figs. 1B and 2C). Agglomeration and low expansion
(<2.0-fold) were also found in a large dynamic suspension culture
(a spinner ﬂask) without hydrogel scaffold (SI Appendix, Fig. S2).
No signiﬁcant difference was found between using mTeSR and E8
or between with 1-d or 4-d RI for these static-suspension cultures
(Figs. 1B and 2C). In summary, a combination of 10% (wt/vol)
PNIPAAm-PEG, 4-d RI, deﬁned E8, medium seeding density
via single-cell or precluster seeding resulted in a high, 10.0-fold
cell expansion in a single 4-d passage (Fig. 1 B and C). Final, ﬁnetuning of conditions revealed that 48 h RI was sufﬁcient to support
this expansion for precluster seeding, 4-d RI was required for
single-cell seeding, and 8% (wt/vol) hydrogel performed as well as
10% (wt/vol) hydrogel (SI Appendix, Fig. S3).
We also assessed whether other, nonthermoreversible materials systems—including UV cross-linked hyarulonic acid (29),
agarose (28), and alginate hydrogel (24)—could support high
level hPSC expansion. We generated and used these materials as
described previously, in conjunction with E8 and RI. For singleseeded iPS-MSCs, moderate expansion (∼2.8-fold) was seen only
in alginate hydrogel with medium seeding density. A slightly
higher, ∼5- or 6.5-fold expansion was achieved in agarose or
alginate hydrogel for preclustered iPS-MSCs, respectively (SI
Appendix, Fig. S4), although these numbers do not approach the
levels of expansion observed with the thermoreversible material.
The multifactorial optimization thus resulted in an effective,
completely deﬁned system for hPSC culture, which was then
characterized in greater detail. For both single-cell and cluster
seeding, live/dead staining revealed very high viability within the
hydrogel or spheroids (Fig. 3A). Also, 5-ethynyl-2′-deoxyuridine
(EdU) staining showed uniform cell proliferation across spheroids, suggesting effective transport of nutrients, oxygen, and/or
protein factors within the hydrogel and spheroids (Fig. 3B).
Microscopy also revealed that single-seeded cells expanded and
grew into spheroids with a narrow size distribution (e.g., 40–120
μm in diameter at day 5, Fig. 3C), whereas precluster seeding
resulted in spheroids with larger sizes and broader distribution
(50–300 μm in diameter at day 5, Fig. 3C). For both seeding
methods, 10-, 20-, or 21-fold expansion, with ﬁnal yields of ∼1,
2.0, or 2.1 × 107 cells per mL hydrogel, was achieved for hPSCs
on day 4, 5, or 6 of the culture, respectively (Fig. 3D). Furthermore, immunostaining showed 95% of cells expressed pluripotency markers octamer-binding transcription factor 4 (Oct4)
and Nanog, and alkaline phosphatase expression was both high
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Fig. 1. A multifactorial experiment was designed to investigate the potential interactions between various system parameters. iPS-MSCs were cultured in
static liquid medium without hydrogel (static suspension) or in 10% (wt/vol) PNIPAAm-PEG hydrogel via single-cell or precluster seeding for 4 d in mTeSR or E8
with 1- or 4-d RI at low, medium, or high seeding density (2.5 × 105, 1.0 × 106, or 2.5 × 106 cells/mL, respectively). (A) Schematic illustration of hPSC culture in
3D hydrogel. (B and C) Fold of expansion and ﬁnal cell densities. The triple asterisk (***) indicates statistical signiﬁcance at a level of P < 0.001.

and homogeneous across spheroids (Fig. 3 E–G). An additional
13-d culture was conducted to explore the sensitivity of cellular
growth and pluripotency to spheroid size in this system. Single
Lei and Schaffer

iPS-MSCs were cultured in PNIPAAm-PEG hydrogel with E8
and RI for 13 d without passaging. An extremely low density (1.0 ×
105 cells per mL) was used to provide sufﬁcient space for cell
PNAS | Published online November 18, 2013 | E5041
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Fig. 2. Phase contrast images showing the cell morphologies for the factorial-designed experiment. iPS-MSCs were cultured in 10% PNIPAAm-PEG hydrogel
via single cell (A) or precluster seeding (B) or in static liquid medium without hydrogel (static suspension) (C) for 4 days in mTeSR or E8 with 1d or 4d RI at low,
medium or high seeding density (2.5×105, 1.0×106, or 2.5×106 cells per mL, respectively). (Scale bar: 250 μm.)

growth during the long 13-d culture. iPS-MSCs grew into spheroids with mean diameter of ∼350 μm, with the larger spheroids
reached diameter up to ∼750 μm. Consistent cell growth and
pluripotent marker expression were also seen in this size range
(SI Appendix, Fig. S5). In summary, the culture system efﬁciently
expanded hPSCs with high quality and density.
We next assessed the generality of this system for the longterm expansion of multiple hPSC lines (1, 33), which were conE5042 | www.pnas.org/cgi/doi/10.1073/pnas.1309408110

tinuously propagated for up to 60 passages or ∼280 d (with
passaging every 4 or 5 d). During each of these passages, iPSMSCs, iPS-Fib2 iPSCs, and H9 hESCs expanded ∼10- or 20-fold
over 4 or 5 d, respectively, and H1 hESCs expanded 7-fold over
4 d, indicating some differences in growth rates among the lines
(Fig. 4A). However, during this long-term culture with an accumulated expansion up to ∼1072-fold, ∼95% of cells remained
Oct4+ (Fig. 4B). Immunostaining again revealed uniform Nanog
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Fig. 3. A 6-d culture of hPSCs in 3D thermoreversible hydrogel. For both seeding methods, Live/Dead cell staining revealed a very high viability (A), and EdU
pulse labeling demonstrated that cells proliferated uniformly across the spheroid (B). Spheroids on day 5 after precluster seeding are shown in A and B. (C)
The morphology of spheroids on days 1 and 5 for both seeding methods and their size distribution are shown. The expansion fold and yield (cells per milliliter
of hydrogel) on days 4, 5, and 6 were quantiﬁed (D). Immunostaining of spheroids, following precluster seeding and 3D hydrogel culture, shows that the
majority of cells expressed the pluripotency markers alkaline phosphatase (E) as well as Oct4 and Nanog (F). (G) Approximately 95% of cells were Oct4+ or
Nanog+. iPS-MSCs were used for A–G. The triple asterisk (***) indicates statistical signiﬁcance at a level of P < 0.001. (Scale bar: 250 μm.)

and Oct4 expressions within spheroids (SI Appendix, Fig. S6). To
our knowledge, this is the highest reported level of hPSC expansion in a culture system.
To assess whether cellular proliferation rates remained consistent over time, we reevaluated the growth kinetics of hPSCs
after 10 passages in the gel. Notably, the expansion rate (∼10-, 20-,
or 21-fold at days 4, 5, or 6, respectively) (SI Appendix, Fig. S7),
pluripotency marker expression, and spheroid size distribution
(SI Appendix, Fig. S7) were similar to those at passage 1 (Fig. 3).
To further establish maintenance of cell pluripotency, embryoid body (EB) differentiation in vitro and teratoma formation in vivo were conducted after long-term culture within the
hydrogel. Each cell line (iPS-MSC, iPS-Fib2, H9, H1) could
undergo differentiation into the three germ layers, with expression of endodermal (HNF3β), mesodermal (αSMA), and ectodermal (Nestin) markers (Fig. 5A and SI Appendix, Fig. S8).
Additionally, each hPSC line formed teratomas after 6–12 wk in
vivo, and neural rosettes and epidermis from ectoderm, cartilage
and muscle from mesoderm, and gut-like structure from endoderm were observed (Fig. 5B and SI Appendix, Fig. S9). In addition, hPSCs remained karyotypically normal after long-term
culture within the gel (Fig. 5C and SI Appendix, Fig. S10).
To further assess whether hydrogel culture maintained cell
behavior in 2D, after every 40 d in 3D, a passage of the hPSCs was
returned to standard 2D surfaces. Dissociated cells attached to
surfaces coated with vitronectin and grew into compact colonies
after 4 d (SI Appendix, Fig. S11 A and B), and these cells could
Lei and Schaffer

subsequently undergo long-term expansion on 2D and maintain
high Oct4+ levels (SI Appendix, Fig. S12). hPSCs could then be
returned to the 3D culture system for additional expansion, indicating that cells can be interchanged between 2D and this 3D
system as needed. Finally, cell banking is important for downstream applications, and hESCs expanded within the 3D system
could be cryopreserved as single cells (SI Appendix, Fig. S11C).
Because suspension cultures are favored for large-scale production, we also demonstrated the hydrogel could readily be
extruded into ﬁbers (∼2 mm in diameter) with encapsulated
cells. Suspension of these ﬁbers in 3D liquid culture resulted in
∼19.5-fold expansion within 5 d for both single-cell and cell
cluster seeding (SI Appendix, Fig. S13), yielding sufﬁciently high
densities of encapsulated cell mass that the hydrogel ﬁbers were
opaque (SI Appendix, Fig. S13B). The pluripotency marker expression and spheroid size distribution (SI Appendix, Fig. S13 C
and D) were indistinguishable from cells grown in hydrogels cast
within a culture well (Fig. 3).
Biomedical applications for hPSCs entail differentiation into
speciﬁc lineages, and we thus investigated whether cells after
long-term culture in this system could then be directed into
ectodermal, endodermal, or mesodermal lineages within the
3D material (Fig. 6). First, after a 4-d expansion in E8 medium
and 9-d differentiation in neural induction medium with small
molecule SMAD inhibitors in the 3D hydrogel (10), ∼80% of
H9-derived cells became positive for the neural progenitor
markers Nestin and Pax6 (Fig. 6A). In a parallel culture, a 4-d
PNAS | Published online November 18, 2013 | E5043
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expansion in E8 medium and 5-d differentiation in endoderm
induction medium (4) in the 3D hydrogel resulted in ∼95% of H9
or iPS-MSC–derived cells being positive for the endoderm progenitor markers forkhead box protein A2 (FOXA2) and SOX17
(Fig. 6B). Finally, a 4-d expansion in E8 medium and 9-d differentiation in cardiomyocyte induction medium (34) within the
3D hydrogel yielded beating spheroids 2 d after transfer to a ﬁbronectin-coated plate (Movie S1).
Several clinical trials have demonstrated that fetal ventral
midbrain tissue implants can alleviate motor symptoms in Parkinson patients under certain circumstances, although this approach is challenged by tissue supply and other considerations
(35, 36). In recent important work, Kriks et al. (10) and Kirkeby
et al. (37) developed approaches for differentiating hPSCs into
DA progenitors or neurons that could functionally integrate into
the brains of mouse, rat, and nonhuman primate models of PD.
We investigated whether the differentiation protocols—which
included both deﬁned (Noggin, Shh, FGF8, TGFβ3) and undeﬁned protein components—could be adapted to 3D culture
under deﬁned conditions. DA induction of H9 spheroids (40–120
μm) within the hydrogel was initiated via dual SMAD inhibition,
Shh, and a GSK3β inhibitor to activate Wnt signaling (Fig. 7A).
On day 11, 81% of cells within the spheroids (∼100–300 μm)
were positive for the ventral midbrain DA progenitor markers
FOXA2 and LMX1a (Fig. 7 B–D). These matched levels obtained in 2D; however, cells in 3D expanded ∼80-fold over 15 d,
resulting in 8 × 107 cells per mL of hydrogel, compared with only
an approximately ninefold expansion on 2D surface (Fig. 7D).
Finally, these DA progenitors could subsequently be cultured on
2D surfaces as described (37) for differentiation into mature TH+
DA neurons (Fig. 7E).
Discussion
Large numbers of hPSCs, or their differentiated progeny, are
needed for many biomedical applications (9). For large-scale
expansion, currently hPSCs from a cell bank are expanded into
large numbers through progressive proliferation followed by directed differentiation into progenitors or mature cells. Efﬁcient,
E5044 | www.pnas.org/cgi/doi/10.1073/pnas.1309408110

scalable, and GMP-compliant culture systems are required for
such processes (9). hPSC culture has made considerable progress, but current systems achieve only moderate expansion, yield,
and quality (9) (SI Appendix, Table S1). The most effective
system reported to date enabled approximately threefold to
fourfold expansion of hESCs per passage in mTeSR medium
containing 1% BSA, for a ﬁnal yield of <1 × 106 cells per mL
(18) (SI Appendix, Table S1). We have developed a 3D culture
system—which combines a synthetic thermoreversible hydrogel
and deﬁned medium with an optimized protocol involving singlecell passaging—for simple, deﬁned, scalable, and GMP-compliant
hESC and hiPSC expansion (Figs. 1–5) and differentiation (Figs.
6 and 7) with high yield. Long-term culture (>280 d) with high
expansion rate (20-fold over 5 d, or 6.4 × 107-fold over 1 mo, and
1072-fold over 280 d), volumetric cell yield (2 × 107 cells per mL
of hydrogel), and quality (∼95% Oct4+) were achieved (Figs. 3
and 4). Additionally, the hPSCs were able to differentiate into all
of the three germ layers after long-term culture in the 3D system
(Fig. 5 and SI Appendix, Figs. S8 and S9). Finally, the 3D system also
supported directed differentiation into neural progenitors, endoderm progenitors (Fig. 6), beating cardiomyocytes (Movie S1), or
midbrain dopaminergic progenitors (Fig. 7) by simply replacing
the expansion medium with the differentiation medium. This
versatile system thus combines many advantageous and important features.
The survival and proliferation of hESCs and hiPSCs—which
both exhibit characteristics typical of epiblast-like pluripotent stem
cells (14)—depend on multiple extracellular cues. These include
soluble protein growth factors [e.g., FGF2, TGF-β, and autocrine/
paracrine cues (15)] that signal via a number of pathways to support cell survival and pluripotency factors [e.g., Nanog, Oct4, Sox2
(38–40)]. In addition, hPSCs engage in cell–matrix interactions
(31), and cell–cell contacts via cadherins are particularly important
for survival and pluripotency maintenance. Disruption of such
cell–cell contacts leads to Abr-dependent activation of RhoA (and
inactivation of Rac1), ROCK activation, and downstream actomyosin hyperactivation and apoptosis (14, 32). Other environLei and Schaffer
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Fig. 5. hPSCs retained pluripotency and normal karyotype after long-term culture in the 3D hydrogel system. (A) EB differentiation in vitro. iPS-MSCs were
expanded in the 3D hydrogel for 35 passages via single-cell seeding before EB differentiation. Immunostaining for the three germ layers (ectoderm: Nestin;
mesoderm: αSMA; and endoderm: HNF3β) are shown. (B) Teratoma formation in vivo. iPS-MSCs expanded in 3D hydrogels for 35 passages via single-cell
seeding were injected into mice s.c., and teratomas formed after 6–12 wk. Structures from all three germ layers (arrows) were identiﬁed, including ectoderm:
neural rosette and epidermis; mesoderm: cartilage and muscle; and endoderm: gut-like-structure. (C) iPS-MSCs cultured in the 3D hydrogel for 35 passages via
single-cell seeding retained normal karyotypes. (Scale bars: A, 100 μm; B, 50 μm.)

mental stress, such as mechanical forces (9, 41) or apparently
redox conditions (3), can also adversely affect cell function.
Through a combination of rational and empirical investigation, this culture system based on a thermoresponsive material
apparently addresses a number of these needs. Importantly,
multifactorial investigation indicated that the system’s properties
may result from a combination of the synthetic PNIPAAm-PEG
matrix, deﬁned medium, and optimized protocol, as any of these
elements alone yielded suboptimal outcomes (Figs. 1 and 2, and
SI Appendix, Figs. S1–S5 and S13–S15). The culture medium
provides key soluble cues (3), and the material may conceivably
concentrate autocrine/paracrine factors near cells (15). RI ameliorates dissociation-induced apoptosis that otherwise occurs via
cytoskeletal-associated pathways (14, 31, 32), and future invesLei and Schaffer

tigation may elucidate whether this mechanically soft (SI Appendix, Fig. S14) thermoresponsive material may more favorably
interface with these mechanosensitive pathways relative to other
materials (14). The material also protects cells from shear-induced
stress, yet this readily deformable hydrogel may more favorably
allow single-cell division and subsequent cluster growth relative to
chemically cross-linked hyaluronic acid, ionically associated alginate, or stiff agarose hydrogels. Finally, E8 unlike mTeSR lacks
β-mercaptoethanol, an apparent stressor of hESCs, particularly
in suboptimal culture environments (SI Appendix, Fig. S15). A
combination of factors thus interacts to provide a permissive 3D
system that supports hPSC biology, and future investigations may
elucidate the mechanistic contributions of both biochemical and
mechanical features of this microenvironment.
PNAS | Published online November 18, 2013 | E5045
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hydrogel could yield >1011 cells for clinical studies. The ability to
move a single culture system through multiple scales may aid
clinical development.
Advances in developmental and stem cell biology have enabled the development of approaches to effectively differentiate
hPSCs into numerous additional cell types, such as neural crest

The system can also be adapted to multiple scales—from the
laboratory toward the clinic—to support research in cell replacement therapies, artiﬁcial tissues and organs, and/or highthroughput drug screening/toxicity screening with hPSCs. For
instance, ∼50 mL of hydrogel would be sufﬁcient to produce 109
cells for preclinical animal studies, and a bioreactor with ∼5 L of
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Phase images showing spheroid morphologies during the 15-d production process, as well as spheroids released from the hydrogel on day 11. (C) Immunostaining on day 11 for the midbrain DA progenitor makers FOXA2 and LMX1a. (D) The fold of expansion and percentage of FOXA2 and LMX1a doublepositive cells on day 11 in the 3D hydrogel system or on the conventional 2D surface. (E) The day 11 DA progenitors produced in the 3D system matured into
TH+ DA neurons after 11 additional days in culture on 2D laminin surfaces. hPSCs cultured in the 3D system for 20–30 passages were used for these differentiation. The triple asterisk (***) indicates statistical signiﬁcance at a level of P < 0.001. (Scale bars: B, 250 μm; C and E, 100 μm.)

E5046 | www.pnas.org/cgi/doi/10.1073/pnas.1309408110

Lei and Schaffer

EB Differentiation. hPSCs were suspended in DMEM plus 20% (vol/vol) FBS plus
10 μM β-mercaptoethanol in low adhesion plates for 6 d. The EBs were then
transferred onto plates coated with 0.1% gelatin and cultured in the same
medium for another 6 d, followed by ﬁxation and staining as above.

Maintaining hPSCs on 2D Surface. Human ESC lines H1 and H9 were obtained
from WiCell Research Institute. iPS-MSC (33) (derived from human MSCs) and
iPS-Fib2 (33) (derived from human dermal ﬁbroblasts) were gift from George
Q. Daley (Children’s Hospital Boston, Boston). hPSCs were cultured on sixwell plate coated with vitronectin (Invitrogen) in E8 medium (Invitrogen). Cells
were passaged every 4 d with 0.5 mM EDTA (Invitrogen). To replate hPSCs on
2D surfaces following expansion within the 3D hydrogel, hPSC spheroids were
dissociated with Accutase (Life Technologies) at 37 °C for 10 min, and cultured
on six-well plate coated with vitronectin in E8 medium (supplied with 10 μM
ROCK inhibitor, Y-27632, Selleckchem, for the ﬁrst 24 h).

Teratoma Formation in Vivo. All animal protocols were approved by the
Animal Care and Use Committee of the University of California, Berkeley. A
total of 3 × 106 hPSCs was suspended in 25 μL of PBS plus 25 μL of Matrigel
(BD Biosciences) and injected s.c. at the back of the neck of the SCID Beige
mice (Charles River Laboratory), and teratomas were harvested when sizes
reached 2 cm. The tissue was then ﬁxed with 4% (wt/vol) PFA for 48 h,
dehydrated with 70%, 95%, and 100% (vol/vol) ethanol sequentially, and
defatted with xylene for 2 h before embedding in parafﬁn. The 10-μmthick sections were cut and stained with hematoxylin and eosin.

Expanding hPSCs in 3D Hydrogel. To transfer the culture from 2D to 3D, hPSCs
on Matrigel or vitronectin-coated tissue culture plates were incubated with
Accutase at 37 °C for 5 min and dissociated into single cells. For the single-cell
seeding method, dissociated cells were mixed with PNIPAAm-PEG (Cosmo
Bio) solution dissolved in E8 medium at 4 °C and cast on tissue culture plate,
then incubated at 37 °C for 15 min to form hydrogels before adding warm
E8 medium containing 10 μM ROCK inhibitor. For the precluster seeding
method, dissociated cells were cultured in suspension overnight in low adhesion plates to form small clusters that were subsequently encapsulated
into the 3D hydrogel as mentioned above.
To passage hPSCs within 3D hydrogel, ice-cold PBS was added to the 3D
culture at day 4 or 5 to dissolve the gel. Spheroids were collected by
centrifuging at 200 × g for 3 min, incubated with Accutase at 37 °C for
10 min, and dissociated into single cells for reencapsulation as mentioned
above. The NucleoCounter NC-200 (Chemometec) was used to count cell
numbers. To prepare hydrogel ﬁbers, a 4 °C PNIPAAm-PEG solution containing cells was extruded into room temperature E8 medium through
a 2-mm-diameter tube. The resulting hydrogel ﬁbers were cultured in suspension in E8 medium at 37 °C. Medium was changed daily for all cultures.
To measure spheroid sizes, hPSCs were released from the hydrogel, and
phase images were taken. The diameters of >2,000 spheroids were quantiﬁed with MetaXpress software (Molecular Devices). The frequency of
spheroids within a diameter range was calculated with the Excel Histogram
Plug-in. Expanded cells were cryopreserved as single cells in E8 medium with
10% (vol/vol) DMSO and 10 μM ROCK inhibitor in liquid N2.

Karyotype. Kyarotyping was performed by Oakland Children’s Hospital
Cytogenetics Laboratory.

Staining and Imaging. Cells cultured on 2D surfaces were ﬁxed with 4% (wt/vol)
paraformaldehyde (PFA) at room temperature for 15 min, permeabilized with
0.25% Triton X-100 for 15 min, and blocked with 5% (vol/vol) goat serum for 1 h
before incubating with primary antibodies at room temperature for 2 h. After
extensive washing, secondary antibodies in 2% (wt/vol) BSA were added
and incubated for another 1 h. Cells were washed with PBS for three times
before imaging.
To assess the pluripotency marker expression of cells expanded in 3D
hydrogels, hPSCs were dissociated into single cells with Accutase and stained in
suspension. Cells were then placed in 96-well plates and analyzed with an
ImageXpress (Molecular Devices). The percentage of Oct4+ or Nanog+ nuclei
was quantiﬁed with MetaXpress software (Molecular Devices). This process was
used to quantify the PAX6+ and Nestin+ cells after neural induction as well.
To stain spheroids, hPSCs were ﬁxed with 4% (wt/vol) PFA at room temperature for 30 min, and then incubated with PBS plus 0.25% Triton X-100 plus 5%
(vol/vol) goat serum plus primary antibodies at 4 °C for 48 h. After extensive
washing, secondary antibodies in 2% (wt/vol) BSA were added and incubated at
4 °C for 4 h. Cells were washed with PBS for three times before imaging. Staining
without primary antibodies was used as controls for all of the immunostainings.
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Neural Induction (52). Following expansion, hPSCs were cultured in knockout
serum replacement (KSR) medium with 10 μM SB431542 (Selleckchem) and
100 nM LDN193189 (Selleckchem) for 5 d. Starting at day 5, the KSR medium
was gradually replaced by the N2 medium, and cells were harvested at day 9.
KSR medium was as follows: DMEM plus 15% (vol/vol) KSR plus 2 mM glutamine plus 10 μM β-mercaptoethanol. N2 medium was as follows: Neurobasal plus N2 plus B27 (without retinoic acid) plus 2 mM L-glutamine.
Endodermal Induction (4). Following expansion, hPSCs were cultured in RPMI
1640 (Sigma) plus 0.2% FBS plus 100 ng/mL Activin-A (Peprotech) plus 20 ng/
mL Wnt3a (R&D) for 1 d and in RPMI 1640 plus 0.5% FBS plus 100 ng/mL
Activin-A for 2 more days before being ﬁxed and immunostained.
Cardiomyocyte Differentiation (34). Following expansion, hPSCs were cultured
in RPMI 1640 plus B27 without insulin between day 0 and 7, and in RPMI 1640
plus B27 after. The following small molecules were added: 12 μM CHIR99021
(Selleckchem) for days 0–1; 5 μM IWP-2 Inhibitor (Selleckchem) for days 3–5.
Spheroids were released on day 9 to ﬁbronectin-coated plate. Beating cardiomyocytes were ﬁlmed on day 11.
Differentiating hPSCs into Dopaminergic Neuronal Progenitors. hPSCs were
cultured in 50% DMEM/F12 plus 50% (vol/vol) Neurobasal medium (with
1:100 N2 and 1:50 B27) for 11 d following expansion (37). The following
proteins and small molecules were added: 10 μM SB431542; 200 ng/mL
Noggin (R&D) or (100 nM LDN193189); 0.7 μM CHIR99021 and 200 ng/mL
SHH C25II. Cells were harvested at day 11.
Statistical Analysis. Statistical analyses were done using the statistical package
Instat (GraphPad Software). For multiple comparisons, the means of triplicate
samples were compared using the Tukey multiple-comparisons analysis with
the α level indicated in the ﬁgure legend.
Antibodies. Oct4 (Santa Cruz Biotechnology; 1:100), Nanog (Santa Cruz Biotechnology; 1:100), Nestin (Millipore; 1:200), αSMA (Abcam; 1:200), FOXA2/
HNF3β (Santa Cruz Biotechnology; 1:200), PAX6 (Covance; 1:200), LMX1a
(Millipore; 1:1,000), MAP2 (BD Biosciences; 1:1,000), TH (Pel-Freez; 1:1,000),
and SOX17 (R&D; 1:500).
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dead cells, the Click-iT EdU Alexa Fluor 594 Imaging Kit (Invitrogen) was used
to label proliferating cells, and an Alkaline Phosphatase Live Stain (Invitrogen) was used to image alkaline phosphatase.
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cells (42), motor neurons (43), oligodendrocyte progenitors (44,
45), pancreatic progenitors (4, 46), hepatocyte-like cells (47),
retinal cells (48), and others (49, 50). Several of these processes
have even proceeded to clinical trials (51). Future work can
explore integrating these advances into this deﬁned 3D hydrogel
culture system to aid efﬁcient, economical, and reproducible cell
production for multiple future applications.

9. Serra M, Brito C, Correia C, Alves PM (2012) Process engineering of human pluripotent
stem cells for clinical application. Trends Biotechnol 30(6):350–359.
10. Kriks S, et al. (2011) Dopamine neurons derived from human ES cells efﬁciently engraft in animal models of Parkinson’s disease. Nature 480(7378):547–551.
11. Laﬂamme MA, Murry CE (2005) Regenerating the heart. Nat Biotechnol 23(7):
845–856.
12. Roger VL, et al. (2012) Heart disease and stroke statistics—2012 update: A report from
the American Heart Association. Circulation 125(1):e2–e220.
13. Zang R, Li D, Tang I, Wang J, Yang S (2012) Cell-based assays in high-throughput
screening for drug discovery. Int J Biotechnol Wellness Ind 1:31–51.
14. Ohgushi M, Sasai Y (2011) Lonely death dance of human pluripotent stem cells:
ROCKing between metastable cell states. Trends Cell Biol 21(5):274–282.
15. Peerani R, et al. (2007) Niche-mediated control of human embryonic stem cell selfrenewal and differentiation. EMBO J 26(22):4744–4755.
16. Villa-Diaz LG, Ross AM, Lahann J, Krebsbach PH (2013) Concise review: The evolution
of human pluripotent stem cell culture: From feeder cells to synthetic coatings. Stem
Cells 31(1):1–7.
17. McDevitt TC, Palecek SP (2008) Innovation in the culture and derivation of pluripotent
human stem cells. Curr Opin Biotechnol 19(5):527–533.
18. Chen VC, et al. (2012) Scalable GMP compliant suspension culture system for human
ES cells. Stem Cell Res (Amst) 8(3):388–402.
19. Steiner D, et al. (2010) Derivation, propagation and controlled differentiation of
human embryonic stem cells in suspension. Nat Biotechnol 28(4):361–364.
20. Amit M, et al. (2011) Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat Protoc 6(5):572–579.
21. Zweigerdt R, Olmer R, Singh H, Haverich A, Martin U (2011) Scalable expansion of
human pluripotent stem cells in suspension culture. Nat Protoc 6(5):689–700.
22. Nie Y, Bergendahl V, Hei DJ, Jones JMPS, Palecek SP (2009) Scalable culture and
cryopreservation of human embryonic stem cells on microcarriers. Biotechnol Prog
25(1):20–31.
23. Chen AK, Chen X, Choo AB, Reuveny S, Oh SK (2011) Critical microcarrier properties
affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell
Res (Amst) 7(2):97–111.
24. Serra M, et al. (2011) Microencapsulation technology: A powerful tool for integrating
expansion and cryopreservation of human embryonic stem cells. PLoS One 6(8):
e23212.
25. Unger C, Skottman H, Blomberg P, Dilber MS, Hovatta O (2008) Good manufacturing
practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 17(R1):
R48–R53.
26. Medina RJ, Kataoka K, Takaishi M, Miyazaki M, Huh NH (2006) Isolation of epithelial
stem cells from dermis by a three-dimensional culture system. J Cell Biochem 98(1):
174–184.
27. Chayosumrit M, Tuch B, Sidhu K (2010) Alginate microcapsule for propagation and
directed differentiation of hESCs to deﬁnitive endoderm. Biomaterials 31(3):505–514.
28. Stenberg J, et al. (2011) Sustained embryoid body formation and culture in a nonlaborious three dimensional culture system for human embryonic stem cells. Cytotechnology 63(3):227–237.
29. Gerecht S, et al. (2007) Hyaluronic acid hydrogel for controlled self-renewal and
differentiation of human embryonic stem cells. Proc Natl Acad Sci USA 104(27):
11298–11303.
30. Watanabe K, et al. (2007) A ROCK inhibitor permits survival of dissociated human
embryonic stem cells. Nat Biotechnol 25(6):681–686.

E5048 | www.pnas.org/cgi/doi/10.1073/pnas.1309408110

31. Xu Y, et al. (2010) Revealing a core signaling regulatory mechanism for pluripotent
stem cell survival and self-renewal by small molecules. Proc Natl Acad Sci USA 107(18):
8129–8134.
32. Ohgushi M, et al. (2010) Molecular pathway and cell state responsible for dissociationinduced apoptosis in human pluripotent stem cells. Cell Stem Cell 7(2):225–239.
33. Park I-H, et al. (2008) Reprogramming of human somatic cells to pluripotency with
deﬁned factors. Nature 451(7175):141–146.
34. Lian X, et al. (2012) Robust cardiomyocyte differentiation from human pluripotent
stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci USA
109(27):E1848–E1857.
35. Lindvall O (2013) Developing dopaminergic cell therapy for Parkinson’s disease—give
up or move forward? Mov Disord 28(3):268–273.
36. Mendez I, et al. (2008) Dopamine neurons implanted into people with Parkinson’s
disease survive without pathology for 14 years. Nat Med 14(5):507–509.
37. Kirkeby A, et al. (2012) Generation of regionally speciﬁed neural progenitors and
functional neurons from human embryonic stem cells under deﬁned conditions. Cell
Rep 1(6):703–714.
38. Xu R-H, et al. (2008) NANOG is a direct target of TGFbeta/activin-mediated SMAD
signaling in human ESCs. Cell Stem Cell 3(2):196–206.
39. Vallier L, Alexander M, Pedersen RA (2005) Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 118(Pt 19):
4495–4509.
40. James D, Levine AJ, Besser D, Hemmati-Brivanlou A (2005) TGFbeta/activin/nodal
signaling is necessary for the maintenance of pluripotency in human embryonic stem
cells. Development 132(6):1273–1282.
41. Hsieh MH, Nguyen HT (2005) Molecular mechanism of apoptosis induced by mechanical forces. Int Rev Cytol 245:45–90.
42. Lee G, Chambers SM, Tomishima MJ, Studer L (2010) Derivation of neural crest cells
from human pluripotent stem cells. Nat Protoc 5(4):688–701.
43. Hu B-Y, Zhang S-C (2009) Differentiation of spinal motor neurons from pluripotent
human stem cells. Nat Protoc 4(9):1295–1304.
44. Keirstead HS, et al. (2005) Human embryonic stem cell-derived oligodendrocyte
progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25(19):4694–4705.
45. Sharp J, Frame J, Siegenthaler M, Nistor G, Keirstead HS (2010) Human embryonic
stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after
cervical spinal cord injury. Stem Cells 28(1):152–163.
46. Kroon E, et al. (2008) Pancreatic endoderm derived from human embryonic stem cells
generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26(4):
443–452.
47. Duan Y, et al. (2010) Differentiation and characterization of metabolically functioning hepatocytes from human embryonic stem cells. Stem Cells 28(4):674–686.
48. Osakada F, Ikeda H, Sasai Y, Takahashi M (2009) Stepwise differentiation of pluripotent stem cells into retinal cells. Nat Protoc 4(6):811–824.
49. Cheung C, Sinha S (2011) Human embryonic stem cell-derived vascular smooth muscle
cells in therapeutic neovascularisation. J Mol Cell Cardiol 51(5):651–664.
50. Descamps B, Emanueli C (2012) Vascular differentiation from embryonic stem cells:
Novel technologies and therapeutic promises. Vascul Pharmacol 56(5-6):267–279.
51. Trounson A, Thakar RG, Lomax G, Gibbons D (2011) Clinical trials for stem cell therapies. BMC Med 9:52.
52. Chambers SM, et al. (2009) Highly efﬁcient neural conversion of human ES and iPS
cells by dual inhibition of SMAD signaling. Nat Biotechnol 27(3):275–280.

Lei and Schaffer

B

A
mTeSR, day 1

mTeSR, day 5

mTeSR, day 5, Live/Dead

E8, day 1

E8, day 5

E8, day 5, Live/Dead

***
Expansion

8.0

mTeSR

1.2E+07

***

4.0

***

E8
cells/ml gel

C

0.0
1
4
Culture Time (day)

mTeSR

***

4.0E+06

6

E8

40.0

0

mTeSR
% Nanog+

80.0
% Oct4+

8.0E+06

E8

0.0E+00
0

D

mTeSR

1
4
6
Culture Time (day)

E8

80.0

40.0

0.0

0.0
4

6

Culture Time (day)

4

6

Culture Time (day)

Figure S1. Culturing iPS-MSCs in 3D PNlPAAm-PEG hydrogel in mTeSR or E8. Small
clumps of iPS-MSCs were encapsulated in 10% hydrogel and cultured. (A) Spheroids in the
hydrogel on day 1 or 5. (B) Live and dead cell staining of spheroids in the hydrogel on day 5.
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Figure S3. Effect of RI and hydrogel concentration on hPSC expansion: iPS-MSCs were
cultured in 8% or 10% hydrogels (1x106 cells/ml hydrogel) via single cell (A and B, 4-day
culture) or precluster (C and D, 5-day culture) seeding in the presence of ROCK inhibitor
(RI) for 1, 2, 4, or 5 days. The spheroid morphology (A, C), fold of expansion, and % of
Oct4+ and Nanog+ cells (B, D) on day 4 (A, B) or 5 (C, D) are shown. Spheroids were
released from 3D hydrogels before imaging. *** indicates statistical significance at a level
of p<0.001. Scale bar: 250 µm
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Figure S4. Culturing iPS-MSCs in various hydrogels with E8 and RI at low or medium seeding
density via single or precluster seeding. Acrylated hyaluronic acids (60 kDa) were UV crosslinked
in the presence of 0.05% Irgacure 2959 in PBS with cells (PNAS, 2007, 11298). Low melting
agarose (Sigma) was used for preparing the 1% agarose hydrogel (Cytotechnology, 2011, 227).
Alginate (Sigma) solution in HEPES buffer was extruded into 100 mM CaCl2 solution to prepare the
alginate hydrogels (PloS One, 2011, e23212). Cells were cultured for 4 days in E8 + RI and live
dead cell staining was done to evaluate the cell viability. For single cells, moderate expansion
(~2.8-fold) was observed only in alginate hydrogel with medium seeding density. Using
preclustered cells, ~5 or 6.5-fold expansion was achieved in agarose or alginate hydrogel, not as
high as the 10-fold expansion achieved with the thermoreversible PNIPAAm-PEG hydrogel. ***
indicates statistical significance at a level of p<0.001. Scale bar: 250 µm
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Figure S5. A 13-day culture of iPS-MSCs in 3D PNIPAAm-PEG hydrogel. Single iPSMSCs were seeded at low density (1.0x105 cells/ml) to provide sufficient space for cell
growth during the 13-day culture. Cells grew into spheroids with mean diameter of ~350
µm, with larger spheroids reaching diameter of ~750 µm on day 13. Consistent cell
growth and Oct4 expression were seen over the 13-day culture or diameter range. (A)
Phase images. (B and C) Fold expansion and % of Oct4+ cells over spheroid diameter.
Scale bar: 250 µm
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Figure S6. Expression of pluripotent markers Nanog and Oct4 in spheroids. H9s, iPSMSCs, H1s and iPS-Fib2s were cultured in PNIPAAm-PEG hydrogel with E8 medium via
single cell seeding for 60, 60, 20 and 35 passages before immunostaining. Uniform
expression of both markers were seen among spheroids. Scale bar: 100 µm
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Figure S7. The expansion fold, yield (cells/ml hydrogel), % of Oct4+ cells and spheroid
size distribution of iPS-MSCs (A) and H9s (B) on a 6-day culture at passage 10 in 3D
hydrogel. *** indicates statistical significance at a level of p<0.001
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Figure S8. EB differentiation. Immunostaining for the 3 germ layers (ectoderm: Nestin;
mesoderm: αSMA and endoderm: HNF3β). hPSCs were long term cultured in 3D
PNIPAAm-PEG hydrogel via single cell or precluster seeding before differentiation via EB.
“Single, P10” indicates 10 passages via single seeding in 3D hydrogel before EB. Scale bar:
100 µm
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Figure S9. Teratoma formation in vivo. hPSCs expanded in 3D PNIPAAm-PEG hydrogel for
long term were injected into mice subcutaneously. Teratomas formed after 6-12 weeks.
Structures (arrows) from all 3 germ layers were identified, including ectoderm: neural rosette
and epidermis; mesoderm: cartilage and muscle; and endoderm: gut-like-structure. “Single,
P10” indicates 10 passages via single seeding in 3D hydrogel before teratoma assary. Scale
bar: 50 µm
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Figure S10. (continued)
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Figure S10. Karyotyping for long term cultured hPSCs. “H1, P10, single” indicates H1s
were cultured in the 3D PNIPAAm-PEG gel for 10 passages via single cell seeding before
karyotyping
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Figure S11. Phase contrast images or Oct4 staining for iPS-MSC (A) or H9 (B) cells
expanding on 2D surfaces coated with vitronectin for 1 or 4 days. iPS-MSCs and H9s
were cultured in the 3D PNIPAAm-PEG hydrogel for 10 passages before being replated on
the 2D surface. (C) Oct4 staining of H9s at day 4 on 2D surface coated with vitronectin.
H9s were expanded in 3D hydrogel for 10 passages via single cell or precluster seeding
and cryopreserved in liquid N2 for 1 month before replating on 2D surfaces. Scale bar:
100 µm
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Figure S12. Oct4 staining for iPS-MSC, H9, and H1 cells cultured on 2D surfaces
coated with vitronectin for 4 days. hPSCs were cultured in the 3D hydrogel for 10
passages via single cell or precluster seeding, then replated on 2D surface for another
10 passages before staining. Scale bar: 100 µm
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Figure S13. Suspension culture of hydrogel fibers with iPS-MSCs. PNlPAAm-PEG solutions
with iPS-MSCs via single cell or precluster seeding were extruded into fibers and suspended
in medium. (A) The hydrogel fibers (dashed lines highlight the fiber edges) with spheroids at
day 3, 4, and 5 are shown, as well as spheroids harvested on day 5. (B) The fibers with cells
on day 5 appeared white. The expansion rates (C) and Oct4 expression (D) for both seeding
methods after 5 days culture were quantified. Scale bar: (A) 250 µm and (B) 2 mm
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Figure S14. The storage modulus (G’) of PNlPAAm-PEG, alginate, agrose and HA hydrogel
in PBS at 37°C. *** indicates statistical significance at a level of p<0.001
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Figure S15. Culturing iPS-MSCs in PNIPAAm-PEG hydrogel with E8 + 1% BSA + 100
µM β-mercaptoethanol. Single iPS-MSCs were encapsulated at low, medium or high
density and cultured with 1d or 4d RI. (A) Phase images on day 4. No spheroids were
formed. (B) A comparison on cell expansion under E8, mTeSR and E8 plus BSA and βME. Low expansions were seen in mTeSR and E8 plus BSA and β-ME. *** indicates
statistical significance at a level of p<0.001. Scale bar: 250 µm

Table S1: Comparison of 3D culture systems in the literature and the new 3D culture system (1)
Culture Method

Cell Lines

Medium

Seeding Method

Serial
Expansion
(# of
passages)

Yield
(cells/ml)

Fold of
Expansion

mTeSR

Single cells
via TrypLE

3-5

~1x106

2x/7days

hES2,
MF12,
iPS
H1,
H9

mTeSR

Single cells
via
Collagenase

17

1-2x105

4-6x/4days

KSR

No

2-3x105

15x/21days

H9.2
VUB01,
H9,
HUES-9

FBS
KSR

No
No

35x106

70x/28days

(a) Suspension Culture of Cell Aggregates:
hES2,
hPSC aggregates in spinner flask
hES3,
ESI049
hPSC aggregates in TCP

EBs in spinner flask

EBs in STLV bioreactor
EBs in STLV bioreactor with
perfusion and dialysis
EBs in:
STLV bioreactor
Spinner flask with ball
impeller
Spinner flask with paddle
impeller
hPSC aggregates in 125ml
spinner flask

hPSC aggregates in 125ml
spinner flask
EBs in
Spinner flask
Stirred tank with 21% O2
Stirred tank with 4% O2

Fold of
Expansion in
30 days(i)

Cell Quality

Differentiation
Following Expansion?

Ref

Cells started to
differentiate after 5
passages

No

(2)

No

(3, 4)

5-6% converted to
hematopoietic
progenitor after 14
days

(5)

~1.7x105

(ii)

~70
EB formation and
Neural differentiation

(6)
(7)

(8)

1.2x/10days
6.4x/10days
2.2x/10days
I3,
I4,
I6,
H9.2
H9
H9

KSR

mTeSR,
rapamycin
KSR,
FBS

hPSC aggregates in TCP

HES1,
HES2,
H7

KSR

hPSC aggregates in spinner flask

H9,
H1,
HES2

mTeSR(iii),
StemPro(iii
)

Small clumps
via
mechanical
dissociation
Single cells
via accutase

Small clumps
via
mechanical
dissociation
Single cells
via accutase

5

20

9x10

25x/10days

3

4.5x105

1:5
spit/6days

No

Day16
2.2x105
4.0x105
5.2x105

10

21

<1x106

~1.6x104

(9,
10)

(11)

>90% Oct4+

(12)

23.7%
48.3%
48.3% converted to
cardiomyocytes after
16 days
<5x/7days
~100x/5wee
ks

~980

HES1 showed
abnormal karyotype at
Passage 20

4.1x/4days
3.8x/4days
3.2x/4days

~4.0x104
~2.2x104
~6.1x103

Passaging had to be
done on or before 4th
day to avoid
differentiation

(13)

~27.5% converted to
cardiomyocyte on
Day 19

(14)

(b) Suspension Culture of Cells on Microcarriers
SCEDTM4
MEF-CM
Matrigel coated CytodexTM3 in
61
Spinner flask, uncontrolled
Spinner flask, 5% air saturated
Spinner flask, 30% air
saturated
HES2,
MEF-CM
In spinner flask on
HES3
DE53 coated with Matrigel
DE53 coated with laminin

No

Mechanical
dissociation

H1,
HES3

Matrigel coated CytodexTM3 in
TCP

H1,
H9

MEF-CM

Single cells
via trypsin

11

Matrigel coated beads in spinner
flask

HES2,
HES3

mTeSR,
StemPro

TrypLE +
mechanical
dissociation

6 month

Matrigel coated polystyrene
beads in spinner flask

H1,
H9

CM

Trimethylammonium coated
polystyrene bead in TCP

ESI-017

CM

Cultisphere S in spinner flask

SHEF3

KSR,
CM

MEF-CM

No

StemPro

20

No

(c) Suspension Culture of Cells in Alginate Microencapsulation
SCEDTM4
MEF-CM
hESCs on microcarriers in 1.1%
61
alginate microbeads
hESCs in PLL-coated liquid core
microcapsules in static and
spinner flask
hESC clusters in 1.1% calcium
alginate microbeads in static
culture

H9

KSR,
MEF-CM,
FBS

(d) The new culture system introduced in the paperd

6x/11day
15x/11day
7x/12day

1.43x106
1.37x106

10-15x/7day
10-15x/7day

1.5x106

6.8x/14days

1.5x106
1.4x106

8.5x/7day
8.5x/7day

Severe agglomeration

(15)

(16)

~9.7x103

a)
84% Tra-1-60+
74% Tra-1-60+
b) agglomeration seen
a) 76% Oct4+
b) agglomeration seen
90% Oct4+

(18)

~3.8x104

20% converted to
cardiomyocytes on day
16
a) seeding efficiency
was very low
a) agglomeration seen
a) agglomeration seen

>80% converted to
definitive endoderm

(21)

10

Collagen coated CytodexTM3 in
spinner flask
Polystyrene beads in spinner
flask
Laminin coated
Vitronection coated
Laminin coated beads in spinner
flask

Collagenase +
mechanical
dissociation

1.2x106
2.2x106
0.8x106

~5.1x104

2.14x105

5.8x/5day

(17)

(19)

(20)

No

1x106

3445x/8days

No

2x105

2.5x/5days

1

3.5x106

10x/7days

(23)

No

2.8x106

20x/20days

(24)

No

1.6x105

9x/15days

(25)

(22)

~250

Efficient proliferation
and maintenance of
undifferentiated status
for 260 days

(26)

hPSCs in 3D thermoreversible
hydrogel

(a) Suspension culture of cell
aggregates

iPS-MSC,
iPS-Fib2,
H9,
H1

E8

Single cells
via Accutase

>60

~2.0x107

Advantages

Scalable

Easy handling

Reproducible

Good 3D cell-cell, cell-matrix interaction

(b) Suspension culture of cells
on microcarriers





Scalable
Reproducible
Good mass and gas diffusion

(c) Suspension culture of cells in
alginate microencapsulation










Scalable
Reproducible
Protection from shear force
Prevents agglomeration of cells
Good 3D cell-cell, cell-matrix interaction
Scalable
GMP compliant
Easy handling (hydrogel forms at room temperature and
becomes solution at 4ºC)
Protection from shear force
Prevents agglomeration of cells
High expansion rate
High cell yield
Effective mass and gas transport
Good 3D cell-cell, cell-matrix interaction
Compatible with many types of bioreactor

(d) The new 3D culture system
in the paper









10x/4days
20x/5days

6.4x107

~95% Oct4+

>80% converted to
neural lineages

Disadvantages

Difficult to control aggregate size

Difficult to control cell purity

Shear-force-induced cell death

Relatively low expansion rate

Relatively low cell yield (cells/volume)

Severe agglomeration of microcarriers and cells

Shear-force-induced cell death

Relatively low expansion rate

Relatively low cell yield

The processes of coating bead, seeding cells, harvesting cells and
separating beads from cells are time-consuming and cost ineffective

Ineffective mass and gas transport within the alginate hydrogel

Low expansion rate

Low cell yield

The processes of encapsulation and decapsulation (w / EDTA) are timeconsuming and cost ineffective

Abbreviations: CM, conditioned medium; MEF-CM, mouse embryonic fibroblast conditioned medium; KSR, knockout serum replacement; FBS, fetal bovine serum; TCP, tissue culture plate; STLV,
slowly turning lateral vessel; EB, embryonic body; hPSC, human pluripotent stem cell
(i) if serial expansion was demonstrated in the paper, the theoretical Fold of Expansion in 30 days was calculated as: (Fold
(ii) For these with a range instead of an accurate number, the median was taken for the calculation
(iii) mTeSR1 and StemPro medium contain 1% and 2% BSA respectively.

of Expansion per passage)

^ (30)/(days per passage)
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Movie S1. H9s cultured for 20–30 passages in the 3D system were used for the cardiomyocytes differentiation. Single H9s were cultured in the hydrogel for 4 d
before differentiation. On day 9, spheroids were released from the gel and plated on ﬁbronectin-coated plate. The movie was taken at day 11. (Scale bar: 250 μm.)
Movie S1
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